Expressão Gênica/efeitos dos fármacos; Metais/toxicidade; MicroRNAs/genética; RNA Mensageiro/genética; Animais; Arsenitos/toxicidade; Células 3T3 BALB; Cloreto de Cádmio/toxicidade; Transformação Celular Neoplásica/efeitos dos fármacos; Transformação Celular Neoplásica/genética; Perfilação da Expressão Gênica; Saúde; Camundongos; Análise em Microsséries; Compostos Organometálicos/toxicidade; Transdução de Sinais/efeitos dos fármacos; Transdução de Sinais/genética; Compostos de Sódio/toxicidade; Testes de Toxicidade

ADCYAP1; ATSDR; Agency for Toxic Substances and Disease Registry; Al(2)(SO(4))(3); As; As(2)O(3); Bioinformatics; C-MOS; CA; CAMK2A; CASP3; CCNI; CLCC1; CNN1; CNTD1; CO(2); CYP1A1; California; Cd; CdCl(2); Ct; DE; DHFR; DMEM; DNA; DNAJ (Hsp40) homolog subfamily B member 4; DNAJB4; Delaware; Disease; Dulbecco's modified Eagle's minimum essential medium; EDEM3; EDTA; ER degradation enhancer mannosidase alpha-like 3; FBJ murine osteosarcoma viral oncogene homolog; FBS; FGFR; FGFRL1; FOS; FZD4; FZD6; Fc; Fe(2)SO(4); GLO1; HN; HepG2; Homo sapiens bone osteosarcoma cell line; IPA; Ingenuity Pathway Analysis; KCND2; LAMC1; Log; M. musculus; MADD; MAP-kinase activating death domain; MBNL1; MD; MG63; MGD; MTPN; Maryland; Metal; MicroRNA; Mouse Genome Database; Mus musculus; NCAM1; NDFIP1; NK6 homeobox 1; NKX6-1; NUPL2; NY; NaAsO(2); NaVO(3); New York; NiSO(4); OGDH; PBS; PCR; PGM3; PHACTR2; PLXNA2; PM; PPP2CB; Pb; Pb(C(2)H(3)O(2))(2)·3H(2)O; RAB30; RAB30 member RAS oncogene family; RAP2B; RAP2B member RAS oncogene family; RIPK4; RNA; ROS; RT-qPCR; SDS; SFN; SLC1A1; SMAP1; SP1; SP1 transcription factor; SPAM1; SRXN1; STAG2; STAT3; STK4; T lymphocyte cell line; T4; TK6; TLDA; TaqMan low density array; TiO(2); UTR; WI; Wisconsin; ZrO(2); adenylate cyclase activating polypeptide 1; aluminium sulfate; arsenic; arsenic trioxide; cDNA; cadmium; cadmium chloride; calcium/calmodulin-dependent protein kinase II alpha; calponin 1; carbon dioxide; caspase 3; chloride channel CLIC-like 1; complementary deoxyribonucleic acid; cycle threshold; cyclin I; cyclin N-terminal domain containing 1; cytochrome P450 family 1 subfamily A polypeptide 1; degree Celsius; deoxyribonucleic acid; dihydrofolate reductase; ethylenediaminetetraacetic acid; fetal bovine serum; fibroblast growth factor receptor; fibroblast growth factor receptor-like 1; fold change; frizzled family receptor 4; frizzled family receptor 6; glyoxalase I; h; hour; human hepatocellular G2 cell line; human neural glioma cell line; iron sulfate; laminin gamma 1; lead; lead acetate; logarithm; mRNA; messenger RNA; miRNA; microRNA; micromolar; moloney murine sarcoma oncogene; muscleblind-like splicing regulator 1; myotrophin; nM; nanomolar; nedd4 family interacting protein 1; neural cell adhesion molecule 1; nickel sulfate; nucleoporin like 2; oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide); p-value; particulate matter; phosphatase and actin regulator 2; phosphate-buffered saline; phosphoglucomutase 3; plexin A2; polymerase chain reaction; potassium voltage-gated channel Shal-related subfamily member 2; probability value; protein phosphatase 2 catalytic subunit beta isozyme; reactive oxygen species; receptor-interacting serine­threonine kinase 4; reverse transcription quantitative polymerase chain reaction; ribonucleic acid; serine dehydratase; serine/threonine kinase 4; signal transducer and activator of transcription 3; small ArfGAP 1; sodium meta-arsenite; sodium vanadate; solute carrier family 1 member 1; sperm adhesion molecule 1; stratifin; stromal antigen 2; sulfiredoxin 1; thymidine kinase 6 cell line; titanium dioxide; untranslated region; zirconium dioxide; °C; µM